PARSONS CAPITAL MANAGEMENT INC/RI - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 4 filers reported holding CHINA PHARMA HLDGS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PARSONS CAPITAL MANAGEMENT INC/RI ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q4 2019$2,0000.0%10,0000.0%0.00%
Q3 2019$2,000
-33.3%
10,0000.0%0.00%
Q2 2019$3,0000.0%10,0000.0%0.00%
Q1 2019$3,0000.0%10,0000.0%0.00%
Q4 2018$3,000
+50.0%
10,0000.0%0.00%
Q3 2018$2,0000.0%10,0000.0%0.00%
Q2 2018$2,000
-33.3%
10,0000.0%0.00%
Q1 2018$3,000
+50.0%
10,0000.0%0.00%
Q4 2017$2,0000.0%10,0000.0%0.00%
Q3 2017$2,0000.0%10,0000.0%0.00%
Q2 2017$2,000
-33.3%
10,0000.0%0.00%
Q1 2017$3,0000.0%10,0000.0%0.00%
Q4 2016$3,000
+50.0%
10,0000.0%0.00%
Q3 2016$2,0000.0%10,0000.0%0.00%
Q1 2016$2,0000.0%10,0000.0%0.00%
Q4 2015$2,0000.0%10,0000.0%0.00%
Q3 2015$2,000
-50.0%
10,0000.0%0.00%
-100.0%
Q2 2015$4,00010,0000.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q1 2020
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 235,000$157,0000.00%
tru Independence LLC 12,500$8,0000.00%
HRT FINANCIAL LP 59,461$39,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TWO SIGMA SECURITIES, LLC 12,068$8,0000.00%
Renaissance Technologies 838,080$558,0000.00%
UBS Group AG 7,790$5,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders